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Abstract
B-1 cells are important players in the first line of defense against pathogens. According to current
models for the origin of B-1 cells, they either represent a separate lineage from conventional B-2
cells or differentiate from conventional B-2 cells via an intermediate, B-1int, in response to positive
selection by antigen. Here we show that Btk, a Tec family kinase that mediates B cell antigen receptor
(BCR) signaling, is required at multiple stages of B-1 cell development. VH12 anti-
phosphatidylcholine (PtC) IgH transgenic mice provide a model for the induced differentiation of
B-1 cells. This transgene selects for PtC-reactive cells and induces them to adopt a B-1 phenotype.
Both processes have been shown to depend on Btk. To determine whether this is secondary to a
requirement for Btk in the development of mature B-2 cells, we crossed VH12 transgenic mice to
mice expressing low levels of Btk. B-2 cell development occurs normally in Btklo mice despite
reduced responsiveness to BCR crosslinking. Analysis of VH12.Btklo mice reveals that Btk regulates
the B-1int to B-1 transition and/or the survival of splenic B-1 cells, in part via a mechanism
independent of its role in BCR signaling. We also show that Btk mediates the survival of, and
expression of IL-10 by, those B-1 cells that do develop and migrate to the peritoneum. Multiple roles
for Btk in B-1 cell development and maintenance may explain the particular sensitivity of this
population to mutations in components of Btk signaling pathways.
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Introduction
There are two major subsets of B lymphocytes in mice, conventional B-2 cells and B-1 cells.
B-1 cells are less abundant than B-2 cells and have a restricted repertoire that is skewed towards
bacterial and self antigens. They are located predominantly in the peritoneal cavity and display
unique cell surface phenotypes and differential regulation of signaling pathways relative to
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B-2 cells (Martin and Kearney, 2001, Hardy and Hayakawa, 2001, Wortis and Berland,
2001, Rothstein, 2002). B-1 cells are important in the first line of defense against pathogens.
They produce the majority of natural IgM, which is critical in the early phase of the response
to bacterial, viral, and parasitic infections (Paciorkowski et al., 2000, Martin et al., 2001,
Baumgarth et al., 2000). They also give rise to mucosal IgA secreting plasma cells (Kroese et
al., 1989), which are involved in neutralizing pathogens as they enter the organism. B-1 cells
have been implicated as a source of autoantibodies in some models of autoimmune disease
(Murakami et al., 1995), although this is not always the case (Reap et al., 1993).
The origin of B-1 cells is controversial. The lineage hypothesis states that B-1 and B-2 cells
represent separate lineages derived independently from hematopoietic stem cells. Evidence for
this model comes predominantly from bone marrow transplant studies. Adult bone marrow
gives rise to B-2, but not B-1, cells when transferred to irradiated hosts. In contrast, fetal or
neonatal liver is rich in transplantable progenitors for B-1 cells (Hayakawa et al., 1985).
Consistent with this observation, fetal liver B cell precursors express reduced levels of TdT
relative to adult bone marrow, and antibodies produced by B-1 cells tend to have fewer N
regions (Li et al., 1993). Indeed, a progenitor which gives rise to B-1, but not B-2, cells, was
recently discovered in both fetal and adult bone marrow (Montecino-Rodriguez et al., 2006).
Several lines of evidence indicate that B-1 cells can also be induced to differentiate in response
to signals from the B cell antigen receptor (BCR). Immunoglobulin (Ig) transgenes derived
from B-1 cells force the majority of B cells expressing them to adopt a B-1 phenotype (Arnold
et al., 1994, Lam and Rajewsky, 1999, Chumley et al., 2000, Hayakawa et al., 1999, Watanabe
et al., 1999). When only the Ig heavy chain is provided, strong antigen-dependent positive
selection for cells expressing light chains conferring reactivity to the original antigen is
observed (Arnold et al., 1994, Lam and Rajewsky, 1999, Chumley et al., 2000, Hayakawa et
al., 1999, Watanabe et al., 1999). Adoptive transfer experiments in the VH12/Vk4 anti-
phosphatidylcholine (PtC) model provide evidence that B-2 cells can differentiate into B-1
cells via an intermediate population, B-1int (Arnold et al., 2000). BCR specificity is thus an
important regulator of B-1 cell development, suggesting a reason for the restricted repertoire
in this population.
Second, there is a strong correlation between BCR signal strength and B-1 cell numbers.
Increased expression levels of B-1 derived Ig transgenes leads to increased numbers of B-1
cells (Watanabe et al., 1999). In contrast, B-1 favorable Ig transgenes do not force a B-1
phenotype when signals from this BCR are “diluted” by simultaneous expression of a B-2
favorable BCR (1 Watanabe et al., 1999). Mice carrying mutations that reduce BCR signaling
thresholds (Lyn-/-, me, CD22-/-, PD-1-/-, CD72-/-, CD19 transgene) have increased numbers
of B-1 cells (Hardy and Hayakawa, 2001). Conversely, both the transmission of BCR signals
and the development of B-1 cells are impaired by loss of function of CD19, BLNK, CD21,
vav, p85α, PLCγ2, cyclin D2, oct-2, or Btk (Hardy and Hayakawa, 2001).
Btk is a Tec family kinase that mediates many aspects of B cell development and function
(Desiderio, 1997, Satterthwaite and Witte, 2000, Khan, 2001), including transmitting BCR
signals. Btk-/- mice and xid mice, which have a point mutation in Btk, have a block at the T2
to mature transition in the B-2 population (Loder et al., 1999). B-1 cells are also significantly
reduced in these mice (Satterthwaite et al., 1997). Previous studies (Clarke and Arnold,
1998) employed VH12 anti-PtC IgH transgenic mice (subsequently referred to as 6-1), a model
of induced differentiation of B-1 cells, to define which stages of B-1 cell development require
Btk. Clonal expansion and differentiation of anti-PtC B cells beyond B-2 were impaired in
6-1.xid mice (Clarke and Arnold, 1998). Since xid B cells fail to mature efficiently beyond the
transitional stage, it is possible that the impaired B-1 cell differentation stems from reduced
numbers of mature B-2 cells rather than an inability of mature B-2 cells to adopt a B-1
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phenotype. We have previously shown that a transgene expressing 25% of endogenous Btk
levels (Btklo) restores mature B-2 numbers to normal in Btk-/- and xid mice (Satterthwaite et
al., 1997). However, these cells have reduced, but not completely impaired, responses to BCR
crosslinking.
Therefore, we crossed 6-1 transgenic mice to Btklo mice to determine how Btk regulates stages
of B-1 cell development subsequent to the generation of mature B-2 cells. We now demonstrate
previously unappreciated roles for Btk in the transition from B-1int to B-1 cells and/or the
survival of differentiated B-1 cells. We also show that efficient differentiation or survival of
cells beyond the B-1int stage requires Btk-mediated, BCR-independent signals.
Methods
Mice
6-1 mice (IgMa) (Arnold et al., 1994) were maintained on a CB17 (IgMb) background and
crossed either with Btklo (Btk-/- + Btk tg) mice (Satterthwaite et al., 1997) maintained on a
defined C57BL/6 (IgMb) background or Btklo or Lyn-/-Btklo (Satterthwaite et al., 1998) mice
maintained on a mixed C57BL/6 (IgMb) × 129 (IgMa) background. Mixed background mice
used for breeding were screened by flow cytometry of peripheral blood for expression of IgMb
but not IgMa since 129 mice carry the IgMa allele. This ensured that the presence of IgMa in
the progeny was due to expression of the 6-1 transgene. To minimize potential variability due
to mixed genetic backgrounds, littermate controls were used whenever possible. Multiple
independent litters were analyzed with similar results. Mice were genotyped by PCR as
described (Arnold et al., 1994, Satterthwaite et al., 1998 ).
Flow cytometry
Single cell suspensions of spleen, bone marrow, or peritoneal wash were depleted of red blood
cells and stained with combinations of the following reagents: FITC-encapsulated liposomes
(Arnold et al., 1994), anti-IgMa FITC, anti-IgMb FITC, anti-IgM PE, anti-CD5 PE, anti-CD43
PE, anti-CD80 PE, anti-B220 PerCP, anti-CD5 PerCP, anti CD23-biotin + streptavidin-APC
(Caltag, Burlingame, CA). Unless otherwise noted, antibodies are from BD Pharmingen (San
Diego, CA). Samples were run on a Becton-Dickinson (San Jose, CA) FACSCalibur and
analyzed with Cellquest (Becton-Dickinson, San Jose, CA) software. Live cells were gated
based on forward and side scatter.
Survival Assay
Peritoneal cells from pools of several mice per genotype were depleted of red blood cells and
B cells purified by one of two methods: 1) B220+ cells were purified with anti-B220 magnetic
beads using the MidiMACS system (Miltenyi Biotec, Auburn, CA). 2) Cells were stained with
anti-B220 TriColor (Caltag) and anti-CD5 PE (BD Pharmingen). B220+CD5+ cells were
isolated with a MoFlo high-speed sorter (DakoCytomation, Fort Collins, CO). Cells purified
by either method were resuspended in complete RPMI media at 106 per ml and plated in 96
well plates. The number of viable cells remaining per well (3 wells per time point) was
determined by trypan blue exclusion at days 2, 4, and 7.
IL-10 ELISA
Peritoneal cells were depleted of red blood cells, resuspended in complete RPMI media at 2 ×
106 per ml and plated in 96 well plates. After 3 days, culture supernatants were harvested and
subjected to an IL-10 ELISA (BD Pharmingen).
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Peritoneal cells from pools of several mice per genotype were depleted of red blood cells and
B220+ cells were purified from with anti-B220 magnetic beads using the MidiMACS system
(Miltenyi Biotec). Total RNA was prepared using the RNeasy kit (Qiagen, Valencia, CA).
cDNA was generated with a cDNA Archive Kit (Applied Biosystems, Foster City, CA). Real-
time PCR was performed on an ABI 7300 Real Time PCR System (Applied Biosystems) using
TaqMan reagents (Applied Biosystems) specific for mouse IL-10 and the internal control
GAPDH. Data were normalized to GAPDH using the delta Ct method.
Light chain repertoire determination
Splenocytes were depleted of red blood cells and stained with FITC-encapsulated liposomes
(Arnold et al., 1994) and anti-CD23 PE (BD Pharmingen). CD23+ liposome- cells were
isolated with a MoFlo high-speed sorter (Cytomation). RNA was prepared using Trizol reagent
(Life Technologies, Carlsbad, CA). 5’RACE (rapid amplification of cDNA ends; Version 2.0;
Life Technologies) was used to amplify Vk light chains as described in Tatu et al (27) with the
following modifications. Primer sequences were identical, except those used for PCR did not
contain CAU repeats. Amplification products were cloned into the pGEM-T Easy vector
(Promega, Madison, WI). Randomly picked colonies were subjected to cycle sequencing with
BigDye Terminator chemistry (Applied Biosystems) and an ABI Prism 377 automated
sequencer (Applied Biosystems). The GSP2 primer (used for PCR) (Tatu et al., 1999) was also
used for sequencing. Sequences were analyzed using Ig BLAST (GenBank).
Statistical Analysis
Two-tailed Student’s t test was employed.
Results
Btklo Transgene Partially Restores anti-PtC B Cells in 6-1.Btk-/- Mice
To determine how changes in Btk dosage affect the clonal expansion of PtC-specific B cells,
the frequency of cells binding PtC-containing liposomes was assessed in the spleens of 6-1,
6-1.Btklo, and 6-1.Btk-/- mice (Figure 1a). On average, 17% of total splenocytes bound
liposomes in 6-1 mice. In contrast, 6-1.Btk-/- mice had very few detectable anti-PtC cells (1%
of total splenocytes, p = .0003 vs. 6-1). This is consistent with previous reports describing
6-1.xid mice (Clarke and Arnold, 1998). The Btklo transgene partially restored this defect.
Liposome binding B cells were present at an average of 9% of total splenocytes in 6-1.Btklo
mice (p = .0007 vs. 6-1.Btk-/-). However, this was still significantly lower than in 6-1 mice (p
= .02). The incomplete restoration of PtC reactive B cells was not due to a nonspecific inhibitory
effect of the Btk transgene on clonal expansion, because 6-1 mice expressing both the Btk
transgene and the wild type endogenous Btk gene had normal numbers of anti-PtC B cells (data
not shown).
Btk regulates the B-1int to B-1 transition
Previous studies have suggested a model in which anti-PtC B cells differentiate in the spleen
as follows: B-2 (CD23+CD5-CD43-) to B-1int (CD23+CD5+CD43+) to B-1
(CD23-CD5+CD43+) (Arnold et al., 1994, Arnold et al., 2000, Clarke and Arnold, 1998).
Cyclosporin, an inhibitor of the Ca++ dependent phosphatase calcineurin, prevents the latter
step. Since Btk regulates BCR-induced Ca++ flux (Rigley et al., 1989, Fluckiger et al.,
1998), we tested whether the B-1int to B-1 transition was affected by reduced Btk dosage. We
used both CD5 and CD43 as independent markers of differentiation as not all B-1 cells express
CD5. anti-PtC B cells were skewed towards earlier steps in differentiation in 6-1.Btklo mice,
with increased frequencies of B-2 cells (p < .003) and fewer B-1 cells (p < .01) as measured
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by either CD5 or CD43 expression (Figure 1b). Taking into account the reduced frequency of
liposome binding cells, the total number of anti-PtC B-2 and B-1int cells were normal in
6-1.Btklo mice while anti-PtC B-1 cells were significantly decreased (p < .05) (Figure 1c).
Thus, we demonstrate here that in addition to its previously appreciated roles in the clonal
expansion of anti-PtC B cells and their differentiation beyond B2 (Clarke and Arnold, 1998),
Btk also controls the B-1int to B-1 transition and/or survival of fully differentiated B-1 cells.
This latter stage is significantly more sensitive than earlier events to subtle changes in Btk
signal strength.
Efficient BCR Signaling is Not Sufficient for Normal B-1 Cell Development
To determine the degree to which PtC-reactive B cells from 6-1.Btklo mice have been
stimulated with antigen in vivo, we measured CD80 expression on B cells from the spleens of
6-1 and 6-1.Btklo mice. anti-PtC cells in other Ig transgenic models express high levels of
CD80, indicative of previous antigen exposure (Chumley et al., 2002). Similarly, almost all
(87 +/- 3%, n=5) liposome-binding cells in 6-1 spleens were CD80+ (Figure 2a). 62 +/- 9%
(n=5) of anti-PtC B cells in 6-1.Btklo spleens expressed CD80. These cells had a B-1int (CD23
+CD5+) or B-1 (CD23-CD5+) phenotype, while the CD80- anti-PtC cells were CD23+CD5-
B-2 cells (Figure 2b). Thus, antigen encounter, as measured by CD80 upregulation, is
associated with differentiation beyond B-2 but is not sufficient to efficiently mediate the
B-1int to B-1 transition.
To further explore the hypothesis that the B-1int to B-1 transition is regulated in part by Btk-
dependent, BCR-independent signals, we compared B-1 cell development in the spleens of
6-1.Lyn-/- and 6-1.Lyn-/-Btklo mice. Lyn deficiency restores the ability of Btklo B cells to
signal through the BCR such that Lyn-/- and Lyn-/-Btklo B cells are equally sensitive to BCR
stimulation as measured by proliferation, Ca++ flux, and ERK and Akt activation
(Satterthwaite et al., 1998, Whyburn et al., 2003). However, 6-1.Lyn-/-Btklo mice had a
reduced frequency of liposome-binding B cells (Figure 3a) and a significant skewing of anti-
PtC B cells towards earlier stages of differentiation (B-2, p < .003; B-1int, p < .007; B-1, p < .
005) as measured by both CD5 and CD43 expression (Figure 3b) compared to 6-1.Lyn-/- mice.
This resulted in a selective reduction in the absolute number of PtC-reactive B-1 cells (Figure
3c). Although we cannot rule out the possibility that there are unidentified differences in BCR
responsiveness between Lyn-/- and Lyn-/-Btklo B cells, these results strongly suggest that
differentiation of B-1 cells beyond B-1int and/or the survival of differentiated B-1 cells is
mediated in part by Btk via BCR-independent signals.
Btk Regulates the Survival of Peritoneal B-1 Cells
We examined the consequences of the reduction in splenic B-1 cells for the peritoneal B cell
compartment of 6-1.Btklo mice. The total number of peritoneal cells (4.5 × 106 +/- 1.9 × 106,
n = 5) was reduced compared to 6-1 mice (12.4 × 106 +/- 4.8 × 106, n = 5) (p = 0.03). However,
there was a relatively normal frequency of anti-PtC B cells (Figure 4a), the majority of which
had a B-1 phenotype (Figure 4b). In contrast, 6-1.Btk-/- mice had few liposome-binding
peritoneal B cells (Figure 4a).
B-1 cells normally have a distinct survival advantage over B-2 cells (Chumley et al., 2000,
Wong et al., 2002). The presence of B-1 cells in the peritoneum of 6-1.Btklo mice allowed us
to ask whether Btk regulates the survival of these cells. Since the vast majority of peritoneal
B220+ cells have a B-1 phenotype in both 6-1 and 6-1.Btklo mice (Figure 4b), we isolated
peritoneal B-1 cells with anti-B220 magnetic beads. Results were then confirmed by sorting
B220+CD5+ cells. These approaches were used to avoid stimulating the cells through the BCR
by isolating them via their ability to bind liposomes. With either method, 6-1 Btklo cells
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survived poorly relative to 6-1 cells during one week of culture in media alone (Figure 4c) (p
= .008 at day 4, p = .02 at day 7).
Autocrine production of IL-10 has been shown to mediate the survival of peritoneal B-1 cells
(O’Garra et al., 1992, Ishida et al., 1992, Gary-Gouy et al., 2002). We therefore examined
expression of IL-10 using real time PCR. A significant reduction (p = .01) in IL-10 mRNA
expression was observed in peritoneal B-1 cells isolated from 6-1.Btklo mice compared to 6-1
mice (Figure 4d). Consistent with this observation, peritoneal cells from 6-1.Btklo mice
secreted less IL-10 than their Btk sufficient counterparts (Figure 4e).
Increased Number of non-PtC Reactive CD23+ B Cells in 6-1.Btklo Mice
A dramatic increase in the frequency (Figure 5a) and total number (4.3 +/- 1.5 × 106 vs. 1.4
+/- 0.6 × 106, n = 13, p = .000016) of non-PtC reactive (liposome-) CD23+ B cells was observed
in the spleens of 6-1.Btklo mice relative to 6-1 mice. This was not due to an overall increase
in the number of B220+ cells but rather a skewing away from reactivity to PtC (Figure 1).
These CD23+ liposome- cells still expressed the VH12 transgene as indicated by IgMa staining
(Figure 5a). The CD23+ population of B cells is composed of T2 and mature cells. Of these,
only mature B cells enter the long-lived pool (Loder et al., 1999). Thus, an increased frequency
of mature cells within the CD23+liposome- population might account for the increased
numbers in 6-1.Btklo mice. This was not the case however as both mice had similar frequencies
of T2 and mature cells (Figure 5b).
The relatively limited repertoire of light chains that pair with the VH12 heavy chain results in
a reduced number of immature B cells in the bone marrow of 6-1 mice (Tatu et al., 1999). The
skewing towards non-PtC reactive B cells in 6-1 Btklo spleens suggested that this checkpoint
may be relaxed upon reduced Btk signaling. However, there was no significant difference in
bone marrow B cell populations between 6-1 and 6-1.Btklo mice, and both strains had fewer
IgM+ B cells than wild type mice (Figure 5c). This indicates that restriction of the light chain
repertoire in 6-1 mice is independent of Btk signal strength.
To directly address this hypothesis, we compared the light chains expressed by CD23+
liposome- cells in the spleens of 6-1 and 6-1.Btklo mice (Figure 5d). We did not observe a
dramatic overall shift in the light chain repertoire in the context of reduced Btk dosage. If
anything,Vk4/5, which can confer PtC reactivity to VH12 (Tatu et al., 1999), was present at a
slightly increased frequency in CD23+liposome- cells from 6-1.Btklo mice. Thus, the increased
in non-PtC-reactive cells in 6-1.Btklo mice is not due to either an overall shift in the light chain
repertoire or selection against light chains that have the potential to contribute to an anti-PtC
antibody.
Discussion
Btk is critical for the development of B-1 cells. The 6-1 transgene has been used to show that
clonal expansion of PtC-specific B cells and their differentiation beyond B-2 is impaired in the
spleens of xid (Clarke and Arnold, 1998) and Btk-/- mice (Figure 1). When a low level of Btk
is provided to B cells in 6-1.Btk-/- mice, normal numbers of PtC-reactive B-2 and B-1int cells
are restored. The frequency and total number of anti-PtC B-1 cells remains dramatically
reduced, however, revealing an additional role for Btk in either the transition from B-1int to
B-1 cells or the survival of differentiated B-1 cells. These observations provide genetic
evidence to support the previously proposed model, based on adoptive transfer studies, that
splenic B-1int cells can give rise to splenic B-1 cells (Arnold et al., 2000). This developmental
transition is significantly more sensitive to changes in Btk signal strength than is differentiation
from B-2 to B-1int, which requires Btk (Clarke and Arnold, 1998) but occurs normally in
6-1.Btklo mice.
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Despite the relatively severe reduction in the number of anti-PtC B-1 cells in the spleen,
peritoneal anti-PtC B cells from 6-1.Btklo mice have a B-1 cell surface phenotype. Splenic B-1
cells, but not B-2 cells, home to the peritoneum in response to CXCL13 (Chumley et al.,
2002). Thus, it is possible that the limited number of B-1 cells produced in the spleens of
6-1.Btklo mice localize normally to the peritoneum. Alternatively, the peritoneal B-1 cells in
6-1.Btklo mice may derive from B-1 specific progenitors in the bone marrow (Montecino-
Rodriguez et al., 2006) rather than from splenic B-1int cells. Regardless of their origin, these
cells survive poorly compared to their Btk-sufficient counterparts and express reduced levels
of the survival factor IL-10 (Figure 4). Since Btk has also been implicated in the response of
B cells to IL-10 (Go et al., 1990), low levels of this cytokine that may still be produced would
be poorly effective. Additional pro-survival mechanisms may also be impaired in the context
of reduced Btk dosage. The combination of reduced input from the spleen and/or bone marrow
and poor survival of those cells that do reach the peritoneum would lead to the lower absolute
number of peritoneal B-1 cells in 6-1.Btklo mice. Without the 6-1 transgene to focus the
repertoire towards “B-1 favorable” BCR specificities, these two defects would render the B-1
population virtually undetectable in Btklo mice, as we have observed previously (Satterthwaite
et al., 1997, Whyburn et al., 2003).
The correlation between response to BCR stimulation and B-1 cell numbers (Hardy and
Hayakawa, 2001) suggests that BCR signaling is a necessary component of the mechanism by
which Btk exerts its effect on B-1 cells. However, this function of Btk is not sufficient for
normal development and maintenance of the B-1 population. In the absence of Lyn, Btklo B
cells are equally sensitive to BCR crosslinking as B cells expressing normal levels of Btk
(Satterthwaite et al., 1998, Whyburn et al., 2003). Despite this, reduced Btk dosage still leads
to decreased numbers of B-1 cells in Lyn-/- mice (Figure 3). Thus, Btk-mediated, BCR-
independent events are also required. A potential role for IL-10 in this process is described
above. In addition, IL-5 also regulates B-1 cell development and survival (Kopf et al., 1996,
Yoshida et al., 1996) and requires Btk to signal (Koike et al., 1995). Alternatively, Btk may
mediate the contribution of Notch-2 to B-1 cell development. Notch-2 haploinsufficiency
reduces B-1 cell numbers (Witt et al., 2003a), and constitutive Notch-2 signaling results in the
exclusive development of B-1 cells at the expense of B-2 cells (Witt et al., 2003b). Finally,
increased signaling through the small GTPase Rap1 results in an increased frequency of B-1
cells (Ishida et al., 2006.). Both Rap1 and Btk have been shown to regulate integrin activity in
B cells (McLeod et al., 2004, Spaargaren et al., 2003), suggesting another possible connection
between Btk and B-1 cell development. The requirement for multiple Btk-mediated signals
during the late stages of B-1 cell development and/or maintenance may explain the higher
threshold level of Btk required for these processes compared to the earlier transition from B-2
to B-1int cells.
Several studies describing B-1 cell expansion in Lyn-/- mice (Nishizumi et al., 1995, Chan et
al., 1997, Takeshita et al., 1998) have recently been contradicted by reports in which no change
(Whyburn et al., 2003, Harder et al., 2001) or a reduction (Hasegawa et al., 2001) of B-1 cells
was observed. The reason for this discrepancy is unclear. We demonstrate here that in the
absence of Lyn, 6-1 mice can generate normal numbers of PtC-reactive B-1 cells (Figure 3).
If anything, there is a trend towards an increased frequency of B-1 cells within the anti-PtC
population in 6-1.Lyn-/- mice, although this is not statistically significant. Thus, if there is a
defect in Lyn-/- mice in the maintenance of B-1 cells, it is not reflected in the processes
measurable in the anti-PtC VH12 transgene model employed in the current study.
In addition to a decreased level of anti-PtC B-1 cells, 6-1.Btklo mice had an increased number
of CD23+ B-2 cells that did not bind liposomes (Figure 5). This could not be attributed to
differences in the maturity of cells within the CD23+ population, impaired expression of the
VH12 transgene, relaxation of a bone marrow checkpoint restricting light chain usage (Tatu
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et al, 1999), or reduced usage of light chains that have the potential to confer PtC reactivity
(i.e. Vk4/5). The increased representation of mature, non-PtC reactive cells in 6-1.Btklo mice
may result from intermediate BCR signal strength that is sufficient to allow development of
mature B-2 cells but too weak to drive strong positive selection of PtC-specific B cells.
Together with previous studies (Arnold et al., 2000, Clarke and Arnold, 1998), the data
presented here demonstrate that Btk is required for several stages in the skewing of VH12-
expressing B cells toward anti-PtC specificity and a B-1 phenotype (Figure 6). These include
differentiation from B-2 to B-1int, the transition from B-1int to B-1 and/or the survival of B-1
cells in the spleen, and the survival of differentiated B-1 cells in the peritoneum. The latter two
processes have a particularly stringent requirement for Btk, perhaps due to the fact that Btk
exerts these effects by transmitting both BCR-mediated and BCR-independent signals. The
use of an immunoglobulin transgenic model in this study has facilitated the identification of
numerous roles for Btk during the induced differentiation of B-1 cells. However, the recent
identification of a progenitor population in fetal and adult bone marrow that gives rise to B-1,
but not B-2, cells (Montecino-Rodriguez et al., 2006) demonstrates that induced differentiation
from B-2 is not the only mechanism by which B-1 cells can be generated. It will be interesting
to determine whether Btk-mediated signals are also critical for the activity of this progenitor
population.
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Figure 1. Btk regulates anti-PtC B cell expansion and differentiation from B-1intto B-1
Splenocytes from 6-1, 6-1.Btklo, and 6-1.Btk-/- mice were stained with FITC-encapsulated
liposomes, anti-CD5 PE or anti-CD43 PE, anti-B220 PerCP, and anti-CD23 biotin +
streptavidin APC. A) The percentage of lymphocytes in each quadrant is indicated. B)
Liposome-binding cells were gated and analyzed for expression of CD5, CD43, and CD23.
B-2 cells (CD23+CD5- or CD23+CD43-) are in the upper left quadrant, B-1int cells (CD23
+CD5+ or CD23+CD43+) are in the upper right quadrant, and B-1 (CD23-CD5+ or CD23-
CD43+) cells are in the lower right quadrant. Quadrants were defined using mice in which
clear distinctions between populations were observed. The percentage of gated cells in each
quadrant is indicated. Two individual 6-1.Btklo mice are shown in B) to reflect the range of
variability seen in the differentiation state of anti-PtC B cells in these mice. Data in A) and B)
are representative of 10 6-1, 10 6-1.Btklo and 5 6-1.Btk-/- mice. C) The number of splenocytes,
B220+ cells, anti-PtC cells, and B-2, B-1int, or B-1 within the anti-PtC population as defined
by CD23 vs. CD5 or CD23 vs. CD43 are indicated. Each symbol (diamonds) represents an
individual mouse. Bars represent the mean (n = 8-10). * = p < 0.05.
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Figure 2. CD80 is upregulated in B-1intand B-1 cells of 6-1.Btklomice
Splenocytes were stained with FITC-encapsulated liposomes, anti-CD80 PE, anti-CD5 PerCP,
and anti-CD23 biotin + streptavidin APC. A. CD23+liposome- (left) and liposome+ (regardless
of CD23 expression) (right) populations were gated and examined for CD80 expression. B.
CD80- and CD80+ populations within the liposome-binding gate of 6-1 Btklo mice (lower right
histogram in A) were examined for expression of CD23 and CD5. Results are representative
of 5 mice per group.
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Figure 3. Reduced B-1 cell numbers in 6-1.Lyn-/-Btklomice
Splenocytes from 6-1.Lyn-/- and 6-1.Lyn-/-Btklo mice were analyzed as in Figure 1. A) The
frequency of liposome-binding cells is presented as mean +/- SEM. n = 10 for 6-1 and
6-1.Btklo mice, 6 for 6-1.Lyn-/- and 6-1.Lyn-/-Btklo mice. B) Data are representative of 6 mice
per group. C) The total number of cells that are anti-PtC and B-2, B-1int, or B-1 as defined by
CD23 vs. CD5 or CD23 vs. CD43 is indicated. Data are presented as mean +/- SEM, n = 4 for
6-1.Lyn-/- and 5 for 6-1.Lyn-/-Btklo.
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Figure 4. Btk regulates peritoneal B-1 cell survival
A) The frequency of liposome-binding cells among all peritoneal cells is indicated. Data are
mean +/- SD, n = 3 for 6-1, 4 for 6-1.Btklo, and 2 for 6-1.Btk-/-. B) Peritoneal cells were stained
with FITC-encapsulated liposomes, anti-CD5 PE, anti-B220 PerCP and anti-CD23 biotin +
streptavidin APC. Liposome-binding (top) or B220+ (bottom) cells within the lymphoid gate
were examined for CD23 and CD5 expression. Data are representative of 3 mice for 6-1 and
4 for 6-1.Btklo. C) B220+ cells were purified from the peritoneum of pools of 2-3 mice per
group using magnetic beads or flow cytometry. Cells were plated in 96 well plates at 106 per
well. The number of live cells (as measured by trypan blue exclusion) remaining at the indicated
time is indicated. Data represent the mean +/- SEM, n = 6 for 6-1 and 5 for 6-1.Btklo. D) B220
+ cells were purified from the peritoneum of pools of 2-3 mice per group using magnetic beads.
IL-10 mRNA levels were measured by quantitative real-time PCR. GAPDH was used as a
loading control. The relative expression of IL-10 in 6-1.Btklo cells compared to 6-1 wt cells
(100%) is shown as mean +/- SD, n=3. E) Peritoneal cells were cultured at 2 × 106 per ml for
3 days. IL-10 levels in the culture supernatants were measured by ELISA. Each symbol
represents the average of duplicate samples from an individual mouse (n = 3).
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Figure 5. Increased number of CD23+ liposome- B cells in 6-1.Btklomice
A) Splenocytes were stained with FITC-encapsulated liposomes or anti-IgMa FITC and anti-
CD23 biotin + streptavidin APC. Results are representative of 10 mice per group. B)
Splenocytes were stained with anti-CD21-FITC, anti-IgM PE, anti-CD5 PerCP and anti-CD23-
biotin + streptavidin APC. CD23+CD5- cells were examined for expression of CD21 and IgM.
Regions used to define T2 and mature (M) cells and the percentage of gated cells in each region
are indicated. Results are representative of 3 mice per group. C) The frequency of B220+IgM-
(pro and pre B cells), B220lo IgM+ (immature B cells), B220hi IgM+ (recirculating B cells),
B220+CD43+ (pro B cells) and B220+CD43- (pre, immature, and recirculating B cells) among
bone marrow cells is indicated as mean+/- SD, n=3-5. There was no significant difference in
the total number of bone marrow cells recovered. D) CD23+ liposome- cells as defined by the
upper left quadrant in A) were purified by flow cytometry from pools of 4 6-1 and 2
6-1.Btklo spleens. RNA was prepared and Ig light chains amplified by 5’ RACE. 34 individual
clones from 6-1 mice and 38 from 6-1.Btklo mice were sequenced. The percentage of clones
representing each light chain family is shown.
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Figure 6. Model for the role of Btk in the focusing of VH12-expressing B cells toward anti-PtC B-1
cells
Circles represent VH12-expressing cells. Black circles express light chains other than Vk4/5,
stippled circles represent Vk4/5 expressing cells that do not bind PtC, and empty circles depict
anti-PtC cells expressing Vk4/5. In normal mice, the light chain repertoire is focused towards
a limited number of light chains including Vk4/5 due to failure of many light chains to pair
with VH12 and the inability of some light chains that do pair with VH12 to support the
development of mature B cells (Tatu et al., 1999). Development of B cells beyond the T2 stage
is considerably impaired in the complete absence of Btk signaling (xid and Btk-/-) (Desiderio,
1997, Satterthwaite and Witte, 2000, Khan, 2001, Loder et al., 1999) regardless of their
specificity. PtC-specific cells that do develop in xid and Btk-/- mice fail to differentiate beyond
B2 (Clarke and Arnold, 1998). Btklo mice can support differentiation of anti-PtC cells through
the B-1int stage, but only limited numbers of B-1 cells are present in the spleen. Some B-1 cells
do develop and localize to the peritoneum, but they survive poorly and produce reduced levels
of the survival factor IL-10. The current studies do not rule out an additional role for Btk in
the newly described B-1 progenitor population present in fetal and adult bone marrow
(Montecino-Rodriguez et al., 2006).
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